Alex P. Hamilton

CIK: 0001970448

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (33.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

MGRX

MANGOCEUTICALS, INC.

Director

ATXG

ADDENTAX GROUP CORP.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

MGRX
MANGOCEUTICALS, INC.
Jul 28, 2026
Award(A)
Direct
100K shares-
MGRX
MANGOCEUTICALS, INC.
Nov 19, 2025
Sale(S)
Direct
125K shares at avg. $1.22$153K
MGRX
MANGOCEUTICALS, INC.
Sep 9, 2025
Award(A)
Direct
100K shares-
ATXG
ADDENTAX GROUP CORP.
Sep 8, 2025
Sale(S)
Direct
23.1K shares at avg. $0.52$12K
ATXG
ADDENTAX GROUP CORP.
Aug 11, 2025
Award(A)
Direct
23.1K shares-
MGRX
MANGOCEUTICALS, INC.
Apr 10, 2025
Award(A)
Direct
25K shares-

		Type	Shares	Price		Ownership
Jul 28, 2026	MGRX MANGOCEUTICALS, INC.	Award(A)	100,000	-	$0	Direct
Nov 19, 2025	MGRX MANGOCEUTICALS, INC.	Sale(S)	125,000	$1.22	$152,875	Direct
Sep 9, 2025	MGRX MANGOCEUTICALS, INC.	Award(A)	100,000	-	-	Direct
Sep 8, 2025	ATXG ADDENTAX GROUP CORP.	Sale(S)	23,095	$0.52	$12,009	Direct
Aug 11, 2025	ATXG ADDENTAX GROUP CORP.	Award(A)	23,095	-	-	Direct
Apr 10, 2025	MGRX MANGOCEUTICALS, INC.	Award(A)	25,000	-	-	Direct

1-6 of 6 transactions

About Hamilton Alex P.

Hamilton Alex P. (SEC CIK 0001970448) files insider reports with the SEC as Director of MANGOCEUTICALS, INC. (MGRX) and Director of ADDENTAX GROUP CORP. (ATXG).

Signal8 holds 6 ownership filings by Hamilton Alex P., all Form 4s, filed between Apr 11, 2025 and Oct 6, 2026. Those filings report 6 transactions, from Apr 10, 2025 to Jul 28, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Hamilton Alex P.'s filings is in DALLAS, TX.

Recent filings by Hamilton Alex P.

Jul 28, 2026: Grant or award of MGRX shares (Form 4, code A).
Nov 19, 2025: Open-market sale of MGRX shares (Form 4, code S).
Sep 9, 2025: Grant or award of MGRX shares (Form 4, code A).
Sep 8, 2025: Open-market sale of ATXG shares (Form 4, code S).
Aug 11, 2025: Grant or award of ATXG shares (Form 4, code A).

Other insiders filing for MANGOCEUTICALS, INC. (MGRX)

Cohen Jacob D., Chief Executive Officer
JOHNSTON EUGENE M, CFO
D'Alessio Lorraine Pamela, Director
MYERS KENNY, Director
Isaac Antonios, President

How to read Form 4 transaction codes